Journal article
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
P Odin, KR Chaudhuri, J Volkmann, A Antonini, A Storch, E Dietrichs, Z Pirtošek, T Henriksen, M Horne, D Devos, F Bergquist
Npj Parkinson S Disease | NATURE PUBLISHING GROUP | Published : 2018
Abstract
Motor aspects of Parkinson’s disease, such as fluctuations and dyskinesia, can be reliably evaluated using a variety of “wearable” technologies, but practical guidance on objective measurement (OM) and the optimum use of these devices is lacking. Therefore, as a first step, a panel of movement disorder specialists met to provide guidance on how OM could be assessed and incorporated into clinical guidelines. A key aspect of the incorporation of OM into the management of Parkinson’s disease (PD) is defining cutoff values that separate “controlled” from “uncontrolled” symptoms that can be modified by therapy and that relate to an outcome that is relevant to the person with PD (such as quality o..
View full abstractGrants
Awarded by Horizon 2020 Framework Programme
Funding Acknowledgements
We thank Global Kinetic Corporation, Melbourne, Australia ( manufacturer of the Parkinson's KinetiGraph<SUP>TM</SUP> [PKG<SUP>TM</SUP>]) for providing financial assistance for the SP meetings and ESP Bioscience (Crowthorne, UK), funded by Global Kinetic Corporation, for editorial assistance with the manuscript. We also thank Professor Regina Katzenschlager (Department of Neurology and Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Sozialmedizinisches Zentrum Ost-Donauspital) for her expert opinion and contribution to the initial phase of discussions.